Dr. Erica Clayton graduated the medical school from the Saint Louis University School of Medicine and completed her residency and fellowship program at the University of Pennsylvania Health System. She is specialized in pathology and board certified in anatomic pathology. Dr. Clayton has been in practice for more than 6 years and is affiliated with the Marin General Hospital. During her career, she has also contributed to six publications of medical interest.
Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation ...
Loaiza-Bonilla A Clayton E Furth E O'Hara M Morrissette J; Ecancermedicalscience. 2014 .
Dr. Erica Clayton graduated the medical school from the Saint Louis University School of Medicine and completed her residency and fellowship program at the University of Pennsylvania Health System. She is specialized in pathology and board certified in anatomic pathology. Dr. Clayton has been in practice for more than 6 years and is affiliated with the Marin General Hospital. During her career, she has also contributed to six publications of medical interest.
Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation ...
Loaiza-Bonilla A Clayton E Furth E O'Hara M Morrissette J; Ecancermedicalscience. 2014 .